Skip to main content
Top
Published in: Diabetology International 2/2024

22-09-2023 | Insulins | Original Article

Practice of complementary and alternative medicine use in North Indian children with type 1 diabetes: an exploratory study

Authors: Priyanka Walia, Latika Rohilla, Devi Dayal

Published in: Diabetology International | Issue 2/2024

Login to get access

Abstract

Purpose

Intermittent or concurrent use of Complementary and Alternative medicines (CAM) with insulin may have adverse effects in children with Type 1 Diabetes (T1DM). This study explores the practices of CAM use in children with T1DM.

Methods

An exploratory study was conducted among parents of children with T1DM attending a tertiary-level diabetes clinic. Data were collected using a structured pre-tested questionnaire.

Results

Two-hundred parents were invited; 183 (91.5%) completed the study. The mean age of the children was lower among CAM users than others (7.9 ± 4.3 vs 9.3 ± 4.3 years, p 0.032). The two groups were similar in gender, family income, parental education, and age at diagnosis. Sixty-seven (36.6%) had used CAM. The parents’ reasoning for CAM use was to cure diabetes (62.7%), to improve glycemic control (28.3%), or considering it harmless (17.9%). The most commonly used CAMs were Ayurveda (32.8%) and homeopathic preparations (31.3%). The time interval between diagnosis and CAM use ranged from 1 day to 4 years. The duration of CAM use varied widely; 50.7% used CAM for < 1 month. Only 10 CAM users had HbA1C estimated during CAM use; their mean HbA1C was 12.4 ± 3.6%. Twenty-seven CAM users (40.2%) reported poorer glycemic control; 26.8% had no effect, and the rest had undefined effects due to too short duration of use.

Conclusion

CAM, mostly herbal, is frequently used among children with T1DM in North India and has detrimental effects on glycemic control. This information should be used during diabetes education to avoid medical emergencies related to sub-optimal insulin dosing.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haliloglu B, Isguven P, Yildiz M, Arslanoglu I, Erguven M. Complementary and alternative medicine in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2011;3(3):139–43.CrossRefPubMedPubMedCentral Haliloglu B, Isguven P, Yildiz M, Arslanoglu I, Erguven M. Complementary and alternative medicine in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2011;3(3):139–43.CrossRefPubMedPubMedCentral
2.
go back to reference Tuomilehto J, Ogle GD, Lund-Blix NA, Stene LC. Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Rev. 2020;17(Suppl 1):198–209.PubMed Tuomilehto J, Ogle GD, Lund-Blix NA, Stene LC. Update on worldwide trends in occurrence of childhood type 1 diabetes in 2020. Pediatr Endocrinol Rev. 2020;17(Suppl 1):198–209.PubMed
5.
go back to reference Tabish SA. Complementary and alternative healthcare: is it evidence based? INT J Health Sci (Qassim). 2008;2(1):v–ix.PubMed Tabish SA. Complementary and alternative healthcare: is it evidence based? INT J Health Sci (Qassim). 2008;2(1):v–ix.PubMed
6.
go back to reference Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13(2):126–31.CrossRef Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13(2):126–31.CrossRef
7.
go back to reference Alzahrani AS, Price MJ, Greenfield SM, Paudya LV. Global Prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77:1259–74.CrossRefPubMedPubMedCentral Alzahrani AS, Price MJ, Greenfield SM, Paudya LV. Global Prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77:1259–74.CrossRefPubMedPubMedCentral
8.
go back to reference Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(1):228–35.CrossRefPubMed Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(1):228–35.CrossRefPubMed
9.
go back to reference Arykan D, Sivrikaya SK, Olgun N. Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum. Turk J Clin Nurs. 2009;18(15):2136–44.CrossRef Arykan D, Sivrikaya SK, Olgun N. Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum. Turk J Clin Nurs. 2009;18(15):2136–44.CrossRef
10.
go back to reference McCarty RL, Weber WJ, Loots B, Breuner CC, Vander Stoep A, Manhart L, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med. 2010;16(2):165–73.CrossRefPubMedPubMedCentral McCarty RL, Weber WJ, Loots B, Breuner CC, Vander Stoep A, Manhart L, et al. Complementary and alternative medicine use and quality of life in pediatric diabetes. J Altern Complement Med. 2010;16(2):165–73.CrossRefPubMedPubMedCentral
11.
go back to reference Miller JL, Binns HJ, Brickman WJ. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. Explore. 2008;4(5):311–4.CrossRefPubMed Miller JL, Binns HJ, Brickman WJ. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. Explore. 2008;4(5):311–4.CrossRefPubMed
12.
go back to reference Bayat M, Uslu N, Erdem E, Efe YS, Variyenli N, Arican F, et al. Complementary and alternative medicine used for children with type 1 diabetes mellitus. Iran J Pediatr. 2017;27(4): e11210.CrossRef Bayat M, Uslu N, Erdem E, Efe YS, Variyenli N, Arican F, et al. Complementary and alternative medicine used for children with type 1 diabetes mellitus. Iran J Pediatr. 2017;27(4): e11210.CrossRef
13.
go back to reference Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Altern Med. 2011;2011: 983792.CrossRef Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Altern Med. 2011;2011: 983792.CrossRef
14.
go back to reference Lemay JF, Amin A, Pacaud D. Complementary and alternative medicine use in children and adolescents with type 1 diabetes. Paediatr Child Health. 2011;16(8):468–72.CrossRefPubMedPubMedCentral Lemay JF, Amin A, Pacaud D. Complementary and alternative medicine use in children and adolescents with type 1 diabetes. Paediatr Child Health. 2011;16(8):468–72.CrossRefPubMedPubMedCentral
15.
go back to reference Dhankar M. Complementary and alternative medicine: a cross-sectional observational study in pediatric inpatients. J Evid Based Integr Med. 2018;23:2515690X18765119.CrossRefPubMedPubMedCentral Dhankar M. Complementary and alternative medicine: a cross-sectional observational study in pediatric inpatients. J Evid Based Integr Med. 2018;23:2515690X18765119.CrossRefPubMedPubMedCentral
16.
go back to reference Shrilatha K, Moorthy J, Harini RR, Kaaviya AA, Sabarathinam S, Kumar SM. Prevalence and pattern of use of complementary and alternative medicine in diabetes patients in a south Indian tertiary care teaching hospital. Drug Invent Today. 2019;11(2):274–9. Shrilatha K, Moorthy J, Harini RR, Kaaviya AA, Sabarathinam S, Kumar SM. Prevalence and pattern of use of complementary and alternative medicine in diabetes patients in a south Indian tertiary care teaching hospital. Drug Invent Today. 2019;11(2):274–9.
17.
go back to reference Vishnu N, Mini GK, Thankappan KR. Complementary and alternative medicine use by diabetes patients in Kerala. India Glob Health Epidemiol Genom. 2017;2: e6.CrossRefPubMed Vishnu N, Mini GK, Thankappan KR. Complementary and alternative medicine use by diabetes patients in Kerala. India Glob Health Epidemiol Genom. 2017;2: e6.CrossRefPubMed
18.
go back to reference Soni V, Dayal D. Lead Toxicity due to use of traditional medicines in a child with type 1 diabetes mellitus. Indian Pediatr. 2019;56(1):77–8.PubMed Soni V, Dayal D. Lead Toxicity due to use of traditional medicines in a child with type 1 diabetes mellitus. Indian Pediatr. 2019;56(1):77–8.PubMed
19.
go back to reference Roy K, Sharma R, Gupta P, Jain V. Severe lead toxicity due to ayurvedic medicine in a child with type 1 diabetes mellitus. Indian J Pediatr. 2022;89(1):89–90.CrossRefPubMed Roy K, Sharma R, Gupta P, Jain V. Severe lead toxicity due to ayurvedic medicine in a child with type 1 diabetes mellitus. Indian J Pediatr. 2022;89(1):89–90.CrossRefPubMed
20.
go back to reference Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5(1):8–11.CrossRefPubMedPubMedCentral Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5(1):8–11.CrossRefPubMedPubMedCentral
21.
go back to reference Rohilla L, Gujjar N, Kaur G, Walia P, Dayal D. Financial burden for families of children with type 1 diabetes: a cross-sectional survey from North India. Diabetol Int. 2022;13(4):665–71.CrossRefPubMedPubMedCentral Rohilla L, Gujjar N, Kaur G, Walia P, Dayal D. Financial burden for families of children with type 1 diabetes: a cross-sectional survey from North India. Diabetol Int. 2022;13(4):665–71.CrossRefPubMedPubMedCentral
22.
go back to reference Kifle ZD. Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting. Metabol Open. 2021;10: 100095.CrossRefPubMedPubMedCentral Kifle ZD. Prevalence and correlates of complementary and alternative medicine use among diabetic patients in a resource-limited setting. Metabol Open. 2021;10: 100095.CrossRefPubMedPubMedCentral
23.
go back to reference Fabian E, Toscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58:101–8.CrossRefPubMed Fabian E, Toscher S, Elmadfa I, Pieber TR. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58:101–8.CrossRefPubMed
24.
go back to reference Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case. J Evid Based Complementary Altern Med. 2017;22(3):449–54.CrossRefPubMed Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and its determinant factors among diabetic patients: an Iranian case. J Evid Based Complementary Altern Med. 2017;22(3):449–54.CrossRefPubMed
25.
go back to reference Pumthong G, Nathason A, Tuseewan M, Pinthong P, Klangprapun S, Thepsuriyanon D, et al. Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complement Ther Med. 2015;23:617–25.CrossRefPubMed Pumthong G, Nathason A, Tuseewan M, Pinthong P, Klangprapun S, Thepsuriyanon D, et al. Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complement Ther Med. 2015;23:617–25.CrossRefPubMed
26.
go back to reference Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the management of diabetes mellitus: (patients’ and herbalists’ perspectives). Evid Based Complement Altern Med. 2019;2019:2835691.CrossRef Kasole R, Martin HD, Kimiywe J. Traditional medicine and its role in the management of diabetes mellitus: (patients’ and herbalists’ perspectives). Evid Based Complement Altern Med. 2019;2019:2835691.CrossRef
27.
go back to reference Moravej H, Salehi A, Shamsedini A, Kolouri S, Karamizadeh Z. Complementary and alternative medicine to treat diabetes mellitus type 1 in Southern Iran. Iran J Med Sci. 2016;41(1):71–2.PubMed Moravej H, Salehi A, Shamsedini A, Kolouri S, Karamizadeh Z. Complementary and alternative medicine to treat diabetes mellitus type 1 in Southern Iran. Iran J Med Sci. 2016;41(1):71–2.PubMed
28.
go back to reference Yeh GY, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a National Survey. Am J Public Health. 2002;92:1648–52.CrossRefPubMedPubMedCentral Yeh GY, Eisenberg DM, Davis RB, Phillips RS. Use of complementary and alternative medicine among persons with diabetes mellitus: results of a National Survey. Am J Public Health. 2002;92:1648–52.CrossRefPubMedPubMedCentral
29.
go back to reference Rohilla L, Dayal D, Malhi P, Kaur S, Bharti B, Dhandapani M. Development and evaluation of a culturally tailored education module for type 1 diabetes in a resource-constrained setting: protocol for a mixed-methods study. Int J Clin Trials. 2021;8(3):244–52.CrossRef Rohilla L, Dayal D, Malhi P, Kaur S, Bharti B, Dhandapani M. Development and evaluation of a culturally tailored education module for type 1 diabetes in a resource-constrained setting: protocol for a mixed-methods study. Int J Clin Trials. 2021;8(3):244–52.CrossRef
30.
go back to reference Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Cross-cultural adaptation and psychometric evaluation of Hindi version of diabetes self-management profile-self report in Indian type 1 diabetes patients. Pediatr Diabetes. 2021;22(1):101–11.CrossRefPubMed Barola A, Tiwari P, Bhansali A, Grover S, Dayal D. Cross-cultural adaptation and psychometric evaluation of Hindi version of diabetes self-management profile-self report in Indian type 1 diabetes patients. Pediatr Diabetes. 2021;22(1):101–11.CrossRefPubMed
32.
go back to reference Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed Rohilla L, Kaur S, Duggal M, Malhi P, Bharti B, Dayal D. Diabetes self-management education and support to improve outcomes for children and young adults with type 1 diabetes: an umbrella review of systematic reviews. Sci Diabetes Self Manag Care. 2021;47(5):332–45.CrossRefPubMed
33.
go back to reference Dayal D, Yadav J, Kumar R, Gupta S, Yadav A, Nanda P. Glycaemic control and factors affecting it in type 1 diabetes in children: experience from a tertiary care centre in India. Pediatr Endocrinol Diabetes Metab. 2022;28(4):281–6.CrossRefPubMedPubMedCentral Dayal D, Yadav J, Kumar R, Gupta S, Yadav A, Nanda P. Glycaemic control and factors affecting it in type 1 diabetes in children: experience from a tertiary care centre in India. Pediatr Endocrinol Diabetes Metab. 2022;28(4):281–6.CrossRefPubMedPubMedCentral
Metadata
Title
Practice of complementary and alternative medicine use in North Indian children with type 1 diabetes: an exploratory study
Authors
Priyanka Walia
Latika Rohilla
Devi Dayal
Publication date
22-09-2023
Publisher
Springer Nature Singapore
Published in
Diabetology International / Issue 2/2024
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-023-00663-9

Other articles of this Issue 2/2024

Diabetology International 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine